I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Rheumatoid Arthritis Diagnosis Tests - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
A Prelude to Rheumatoid Arthritis
Causes and Risk Factors
Symptoms
Rheumatoid Arthritis Diagnostic Tests
Serological Tests
Monitoring RA Treatment Efficiency Tests
Kidney Function Tests
Impact of Covid-19 and a Looming Global Recession
Impact of COVID-19 on Rheumatoid Arthritis Diagnostic Tests
Global Market Outlook and Prospects
Global Rheumatoid Arthritis Diagnostic Tests Market Set to
Witness Significant Growth
Select RA Diagnostic Tests by Player
The US and Europe Dominate the Global Market, Developing
Countries to Witness Fastest Growth
Competition
Recent Market Activity
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Incidence of Rheumatoid Arthritis Propels the Demand for
Rheumatoid Arthritis Diagnosis
Global Cost of Chronic Diseases (In US$ Billion) for the Years
2018 and 2030
Growing Aging Population to Drive the Demand for RA Diagnostic
Tests
Global Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Increasing Use of Rapid Diagnosis Tests Platform
Select List of RA Biomarkers used in Clinical Practice
Investigational Biomarkers to Diagnose and Monitor RA
New Biomarker Tests to Drive the Market Growth
More Specific Biomarker Tests
Growing Demand for Multiple Tests
Repercussions of Sub Optimal Accuracy in RA Testing Drive the
Need for Multiple Tests
Recent Advancements in Treatment Methods to Boost Market Growth
Uptrend in Healthcare Expenditure Drives Opportunities
World Healthcare Expenditure (In US$ Billion) for the Years
2017-2023
Increase in Number of Hospitals & Diagnostics Centers Augurs
Well for Market in Developing Regions
Increasing Obesity Levels Underpins Market Growth
Obesity Prevalence Rate (%) in Select Countries for the Years
2019 and 2030P
Technological Advancements Widen the Capabilities of RA
Arthritis Tests
A Few of the Recent Launches and Advancements
Rapid RA Diagnostic Tests for Obtaining Results in Minutes
imaware? Introduces At-Home Rheumatoid Arthritis Screening Test
Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid
Arthritis Test
Scipher MedicineĀ® Ties Up with Ambry GeneticsĀ® to Bring
Precision Medicine Test for Rheumatoid Arthritis to Market
A New Blood Test Could to Predict Rheumatoid Arthritis
A New Blood Test Could to Predict Rheumatoid Arthritis
IPM Launches Innovative Program for Rheumatoid Arthritis

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Serology Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Serology Tests by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 3: World 15-Year Perspective for Serology Tests by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Monitoring RA Treatment Efficiency Tests by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Monitoring RA Treatment
Efficiency Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Monitoring RA Treatment
Efficiency Tests by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 12: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Ambulatory Surgical Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 16: World Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 19: USA Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: USA 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 22: USA Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 24: USA 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

CANADA
Table 25: Canada Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: Canada 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 28: Canada Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 30: Canada 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

JAPAN
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 31: Japan Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: Japan 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 34: Japan Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Japan Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 36: Japan 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

CHINA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 37: China Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 39: China 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 40: China Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: China Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 42: China 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

EUROPE
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 43: Europe Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Europe Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 45: Europe 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 46: Europe Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 48: Europe 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

Table 49: Europe Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Geographic Region - Percentage Breakdown of
Value Revenues for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2021 & 2027

FRANCE
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 52: France Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 54: France 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 55: France Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: France Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 57: France 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

GERMANY
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 58: Germany Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 60: Germany 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 61: Germany Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 63: Germany 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

ITALY
Table 64: Italy Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: Italy 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 67: Italy Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Italy Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 69: Italy 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

UNITED KINGDOM
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 70: UK Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Rheumatoid Arthritis Diagnosis
Tests by Test Type - Serology Tests and Monitoring RA Treatment
Efficiency Tests Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: UK 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 73: UK Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: UK Historic Review for Rheumatoid Arthritis Diagnosis
Tests by End-Use - Diagnostic Laboratories, Hospitals and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 75: UK 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

SPAIN
Table 76: Spain Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Spain Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 78: Spain 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 79: Spain Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Spain Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 81: Spain 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

RUSSIA
Table 82: Russia Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: Russia Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 84: Russia 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Percentage Breakdown of Value
Revenues for Serology Tests and Monitoring RA Treatment
Efficiency Tests for the Years 2012, 2021 & 2027

Table 85: Russia Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Russia Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 87: Russia 15-Year Perspective for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Percentage Breakdown of Value
Revenues for Diagnostic Laboratories, Hospitals and Ambulatory
Surgical Centers for the Years 2012, 2021 & 2027

REST OF EUROPE
Table 88: Rest of Europe Recent Past, Current & Future Analysis
for Rheumatoid Arthritis Diagnosis Tests by Test Type -
Serology Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Rest of Europe Historic Review for Rheumatoid
Arthritis Diagnosis Tests by Test Type - Serology Tests and
Monitoring RA Treatment Efficiency Tests Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 90: Rest of Europe 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by Test Type - Percentage Breakdown
of Value Revenues for Serology Tests and Monitoring RA
Treatment Efficiency Tests for the Years 2012, 2021 & 2027

Table 91: Rest of Europe Recent Past, Current & Future Analysis
for Rheumatoid Arthritis Diagnosis Tests by End-Use -
Diagnostic Laboratories, Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 92: Rest of Europe Historic Review for Rheumatoid
Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories,
Hospitals and Ambulatory Surgical Centers Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 93: Rest of Europe 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of
Value Revenues for Diagnostic Laboratories, Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2022 (E)
Table 94: Asia-Pacific Recent Past, Current & Future Analysis
for Rheumatoid Arthritis Diagnosis Tests by Test Type -
Serology Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Asia-Pacific Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 96: Asia-Pacific 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by Test Type - Percentage Breakdown
of Value Revenues for Serology Tests and Monitoring RA
Treatment Efficiency Tests for the Years 2012, 2021 & 2027

Table 97: Asia-Pacific Recent Past, Current & Future Analysis
for Rheumatoid Arthritis Diagnosis Tests by End-Use -
Diagnostic Laboratories, Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Asia-Pacific Historic Review for Rheumatoid Arthritis
Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals
and Ambulatory Surgical Centers Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 99: Asia-Pacific 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of
Value Revenues for Diagnostic Laboratories, Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

Table 100: Asia-Pacific Recent Past, Current & Future Analysis
for Rheumatoid Arthritis Diagnosis Tests by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 101: Asia-Pacific Historic Review for Rheumatoid
Arthritis Diagnosis Tests by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 102: Asia-Pacific 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by Geographic Region - Percentage
Breakdown of Value Revenues for Australia, India, South Korea
and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027

AUSTRALIA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Australia for 2022
(E)
Table 103: Australia Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology
Tests and Monitoring RA Treatment Efficiency Tests -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Australia Historic Review for Rheumatoid Arthritis
Diagnosis Tests by Test Type - Serology Tests and Monitoring RA
Treatment Efficiency Tests Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 105: Australia 15-Year Perspective for Rheumatoid
Arthritis Diagnosis Tests by Test Type - Percentage Breakdown
of Value Revenues for Serology Tests and Monitoring RA
Treatment Efficiency Tests for the Years 2012, 2021 & 2027

Table 106: Australia Recent Past, Current & Future Analysis for
Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic
Laboratories, Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Australia Historic Review for Rheumatoid Arthritis

Please contact our Customer Support Center to get the complete Table of Contents